On January 6, Indian markets experienced a downturn, with both benchmark indices declining by approximately 1.6%. The Nifty 50 closed at 23,616.50, and the Sensex settled at 77,946. This dip was primarily attributed to concerns in the banking sector and global economic factors, rather than the recent detection of Human Metapneumovirus (HMPV) cases in India.
In the past few days, two HMPV cases were reported in Karnataka. The Union Ministry of Health is closely monitoring the situation and has sought timely updates from the World Health Organization (WHO). The WHO has indicated that the rise in respiratory illnesses, including HMPV, is typical for the winter season and does not signify an unusual outbreak pattern.
Market experts suggest that the Health Ministry’s statements have alleviated concerns regarding HMPV. Sunny Agrawal, Head of Fundamental Research at SBI Securities, mentioned that the ministry has clarified that HMPV is not comparable to COVID-19, with no indications of travel restrictions or lockdowns.
The market’s downward trend on January 6 was influenced by other factors. Siddarth Bhamre, Head of Research at Asit C. Mehta, noted that disappointing banking business numbers, particularly among PSU banks and HDFC Bank, contributed to the decline. The Nifty PSU Bank Index fell by around 4%, and the Nifty Bank Index decreased by approximately 2%.
Agrawal also pointed to the weakening rupee, linked to the strengthening US dollar index, and muted growth reported by banks during the December quarter as contributing factors. Narendra Solanki, Head of Fundamental Research-Investment Services at Anand Rathi Shares and Stock Brokers, emphasized that global factors, such as weak banking updates and rumors of rate cuts by other central banks, played a more significant role in the market’s performance than concerns about HMPV.
Experts agree that while there may be some nervousness in the markets, the current situation does not warrant major concern. Siddhartha Khemka, Head of Research at Motilal Oswal Financial Services, stated that the market needs clarity from the scientific community before drawing conclusions about HMPV. Nirav Karkera, Head of Research at Fisdom, added that any negative market reactions to the virus are expected to be limited and knee-jerk in nature, with no significant downside anticipated in the absence of further adverse developments.
In summary, the recent market decline is largely due to banking sector concerns and global economic factors, with the emergence of HMPV cases in India having a minimal impact on market sentiment.